文献速递浆细胞疾病

CTPS1是多发性骨髓瘤的新治疗靶点,与CHEK1、ATR或WEE1抑制协同作用

CTPS1 is a novel therapeutic target in multiple myeloma which synergizes with inhibition of CHEK1, ATR or WEE1.
PubMed 文献 · Leukemia · 2023-10-28

研究分析公共数据集发现CTPS1(而非CTPS2)高表达与多发性骨髓瘤(MM)晚期疾病和不良预后相关;CTPS1敲除诱导MM细胞系凋亡,选择性抑制剂STP-B抑制增殖、诱导S期阻滞和凋亡,并激活DNA损伤反应;STP-B与ATR、CHEK1或WEE1抑制剂联用产生协同生长抑制和早期凋亡。

要点

  • CTPS1高表达与MM晚期疾病和不良预后相关,CTPS2无此关联
  • CTPS1敲除诱导MM细胞系凋亡
  • STP-B抑制CTPS1后激活DNA损伤反应,与ATR、CHEK1或WEE1抑制剂联用协同抑制生长并诱导早期凋亡

核心结论

  • CTPS1是MM中有前景的新靶点,可单独靶向或与DNA损伤反应通路抑制联合。

研究设计与样本

  • 研究分析公共数据集,并在MM细胞系中进行细胞实验。

主要发现

  • 公共数据集分析显示CTPS1(而非CTPS2)高表达与晚期疾病和不良预后相关。
  • CTPS1敲除诱导MM细胞系凋亡。
  • STP-B抑制CTPS1后抑制增殖、诱导S期阻滞和凋亡。
  • STP-B抑制CTPS1激活DNA损伤反应通路,诱导双链DNA断裂并在早期S期积累。
  • STP-B与ATR、CHEK1或WEE1抑制剂联用产生协同生长抑制和早期凋亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Targeting nucleotide biosynthesis is a proven strategy for the treatment of cancer but is limited by toxicity, reflecting the fundamental nucleotide requirement of dividing cells. The rate limiting step in de novo pyrimidine synthesis is of interest, being catalyzed by two homologous enzymes, CTP synthase 1 (CTPS1) and CTPS2, that could be differentially targeted. Herein, analyses of publicly available datasets identified an essential role for CTPS1 in multiple myeloma (MM), linking high expression of CTPS1 (but not CTPS2) with advanced disease and poor outcomes. In cellular experiments, CTPS1 knockout induced apoptosis of MM cell lines. Exposure of MM cells to STP-B, a novel and highly selective pharmacological inhibitor of CTPS1, inhibited proliferation, induced S phase arrest and led to cell death by apoptosis. Mechanistically, CTPS1 inhibition by STP-B activated DNA damage response (DDR) pathways and induced double-strand DNA breaks which accumulated in early S phase. Combination of STP-B with pharmacological inhibitors of key components of the DDR pathway (ATR, CHEK1 or WEE1) resulted in synergistic growth inhibition and early apoptosis. Taken together, these findings identify CTPS1 as a promising new target in MM, either alone or in combination with DDR pathway inhibition.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Pfeiffer C, Grandits AM, Asnagli H, et al. CTPS1 is a novel therapeutic target in multiple myeloma which synergizes with inhibition of CHEK1, ATR or WEE1. Leukemia. 2023. PMID: 37898670. doi:10.1038/s41375-023-02071-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。